Acquisition Synergy Aspenti Health is now part of Averhealth, presenting a combined opportunity to cross-sell urine drug testing, toxicology diagnostics, and population health management services to Averhealth’s existing client base.

Expansion Footprint With a Burlington, Vermont base and history of mobile specimen collection units, there is potential to expand mobile testing services to new markets, leveraging operational agility to serve hospitals and treatment centers with on-site collection capabilities.

Integrated Platform Aspenti’s scalable digital and diagnostic health engine for Addiction and Behavioral Health population management can be marketed as an end-to-end platform to hospitals and treatment facilities seeking integrated care management and data-driven outcomes.

Regulatory & Compliance Given the clinical lab and toxicology focus, there are sales opportunities to emphasize compliance, quality assurance, and rapid turnaround benefits to clinics facing stringent regulatory requirements and payer expectations.

SMB to Enterprise Current employee count and revenue positioning suggest a path from smaller treatment centers to larger hospital systems; target mid-market facilities that need scalable testing workflows, analytics, and population health tools to improve addiction care outcomes.